Sandy And Suicide Case Study Essay
“You mean it’s not my fault?,” says Sandy, a 40 year old woman who had just tried to commit suicide the night before she came in for an initial meeting with her psychiatrist, Dr. David Amen. Amen had just tested Sandy using the Single Photon Emission Computed Tomography, or the SPECT. It was his very first time to use the technology to help him in his diagnosis. Her brain scan showed a precipitous drop in activity in the prefrontal cortex, the brain’s decision-making center, whenever she would try to concentrate. Learning that her problem was biological and not simply moral, Sandy was urged to accept her condition and take the prescribed medications. After facilitating Amen’s prescribed treatment method, there was a significant improvement in Sandy’s lifestyle, and it was deduced that, overall, she had been greatly helped. Sandy’s recuperation is Dr. Amen’s Genesis story—the beginning of what has rewarded him with a chain of Amen Clinics, a presence on PBS television program, lucrative speaking engagements, and a line of products that includes books, videos, and diet supplements. This, of
…show more content…
Hall (2007) supports the APA and argues that it is improper to charge thousands of dollars for a test that has not been validated and may not be safe. This is with regard to SPECT imaging using an injected radioisotope to measure the brain’s blood flow, thus exposing patients to unnecessary radiation without accounting for its side effects. The key question here is whether its findings are useful in determining what treatment the patient should receive or not. Is low or high perfusion really an indication of the primary pathology, or is it just a secondary brain response to the symptoms? Perhaps leaving this question unanswered suggests something about Amen’s widely published research. You be the
Hall (2007) supports the APA and argues that it is improper to charge thousands of dollars for a test that has not been validated and may not be safe. This is with regard to SPECT imaging using an injected radioisotope to measure the brain’s blood flow, thus exposing patients to unnecessary radiation without accounting for its side effects. The key question here is whether its findings are useful in determining what treatment the patient should receive or not. Is low or high perfusion really an indication of the primary pathology, or is it just a secondary brain response to the symptoms? Perhaps leaving this question unanswered suggests something about Amen’s widely published research. You be the